World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

THE EVALUATION OF TUMOR MARKERS LEVELS IN PRE AND POSTMENOPAUSAL BREAST CANCER WOMEN

Enas H. Hameed*, Sura Z. Hussein, Nazar A. N. Abed

ABSTRACT

Tumor markers are substances produced by the tumors or by other cells of the body in response to cancer or certain benign conditions. The cancer antigen (CA15-3) and carcinoembryonic antigen (CEA) are tumor markers that are often expressed in people with breast cancer. These tumor markers are most useful for monitoring response to therapy and detecting early relapse. Serum samples were collected from 140 women were ,50 of these women were control and 90 women were breast cancer patients attending to cancer center in Erbil city from Jaunary 2017 to Augest 2017.Study populations classified into three groups which age ranged from (29-65) years, total subjects, pre and postmenopausal women. The results of CEA and CA15-3were showed a highly significant increase (P?0.01) in total and (pre and postmenopausal) breast cancer patients compare with healthy control. Elevated CA15-3 levels are more common in metastatic breast cancer patients than with other tumor markers (e.g., CEA) and concluded from this study CEA and CA15-3 levels were increased, in patients compare to healthy control group.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR